Synthesis, characterization and urease inhibition, in vitro anticancer and antileishmanial studies of Ni(II) complexes with N,N,N′-trisubstituted thioureas

A series of N , N , N ′-trisubstituted thioureas ( 1–12 ) and their Ni(II) complexes ( 1a–12a ) were synthesized and characterized by multinuclear ( 1 H and 13 C) NMR, FT-IR spectroscopy and LC–MS techniques in combination with elemental analysis. The crystal structures of both ligands and Ni(II) ch...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of biological inorganic chemistry 2015-04, Vol.20 (3), p.541-554
Hauptverfasser: Rauf, Muhammad Khawar, Yaseen, Samad, Badshah, Amin, Zaib, Sumera, Arshad, Raffia, Imtiaz-ud-Din, Tahir, Muhammad Nawaz, Iqbal, Jamshed
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A series of N , N , N ′-trisubstituted thioureas ( 1–12 ) and their Ni(II) complexes ( 1a–12a ) were synthesized and characterized by multinuclear ( 1 H and 13 C) NMR, FT-IR spectroscopy and LC–MS techniques in combination with elemental analysis. The crystal structures of both ligands and Ni(II) chelates of type Ni(L- O , S ) 2 were determined by single crystal X-ray diffraction analysis. All the complexes were adopted to have square planar geometry, where the N , N , N ′-trisubstituted thioureas showed bidentate mode of coordination at nickel centre through oxygen and sulfur atoms. The synthesized complexes were screened for potential inhibitors of Jack bean urease. Compounds 1a and 3a were observed as most potent inhibitors of urease exhibiting IC 50 values of 1.17 ± 0.12 and 1.19 ± 0.41 µM, respectively. Cytotoxicity assay on lung carcinoma (H-157) and kidney fibroblast (BHK-21) cell showed that compounds were significant anticancer agents. Additionally, the complexes were tested against Leishmania major and found to be potent antileishmanial agents.
ISSN:0949-8257
1432-1327
DOI:10.1007/s00775-015-1239-5